首页> 外国专利> Combination therapy using 11β-hydroxysteroid dehydrogenase type 1 inhibitors and antihypertensive agents to treat metabolic syndrome and related diseases and disorders

Combination therapy using 11β-hydroxysteroid dehydrogenase type 1 inhibitors and antihypertensive agents to treat metabolic syndrome and related diseases and disorders

机译:使用11β-羟基类固醇脱氢酶1型抑制剂和降压药联合治疗代谢综合征和相关疾病

摘要

Combination therapy comprising the administration of an 11ss-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent useful for treating, preventing and reducing the risk of developing insulin resistance, dyslipidemia, obesity, hypertension and other related diseases and disorders.
机译:组合疗法,包括给予1ss-羟类固醇脱氢酶1型抑制剂和抗高血压药,可用于治疗,预防和降低发生胰岛素抵抗,血脂异常,肥胖,高血压和其他相关疾病和病症的风险。

著录项

  • 公开/公告号JP2006522750A

    专利类型

  • 公开/公告日2006-10-05

    原文格式PDF

  • 申请/专利号JP20060504357

  • 申请日2004-04-06

  • 分类号A61K45/06;A61K31/519;A61K31/55;A61K31/138;A61P3;A61P5/50;A61P3/06;A61P9/12;A61P3/04;A61P3/10;A61P3/08;A61P9;A61P25;A61P27/06;A61P37;A61P21;A61P1/04;A61P15;A61P17/14;A61P5/38;A61P5/44;A61P5/46;A61P35;A61P13/12;A61P9/10;A61P27/02;A61P17/02;A61P1/16;A61P9/04;A61P25/08;A61P9/06;A61P7/06;A61P15/10;A61P19/10;A61P25/18;A61P25/28;A61P25/24;A61P25/22;A61P1/14;A61P25/06;A61P25/30;A61P15/08;A61P37/02;A61P31/04;A61P31/10;A61P31/12;A61P33;A61P37/04;A61P29;A61P11/06;A61P11;A61P19/02;A61P35/02;A61P21/04;A61P41;A61P3/14;A61P43;C07D487/04;C07D401/14;

  • 国家 JP

  • 入库时间 2022-08-21 21:52:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号